{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T20:01:33Z","timestamp":1774987293426,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T00:00:00Z","timestamp":1487894400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s00392-017-1086-1","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T11:23:27Z","timestamp":1487935407000},"page":"551-556","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["High incidence of cardiac dysfunction and response to antiviral treatment in patients with chronic hepatitis C virus infection"],"prefix":"10.1007","volume":"106","author":[{"given":"Wolfgang","family":"Poller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziya","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Muche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Kasner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Skurk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Kappert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf","family":"Tauber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felicitas","family":"Escher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz-Peter","family":"Schultheiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-J\u00f6rg","family":"Epple","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"Landmesser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,24]]},"reference":[{"key":"1086_CR1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1161\/01.RES.0000156077.54903.67","volume":"96","author":"A Matsumori","year":"2005","unstructured":"Matsumori A (2005) Hepatitis C virus infection and cardiomyopathies. Circ Res 96:144\u2013147","journal-title":"Circ Res"},{"key":"1086_CR2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1665-2681(19)31787-9","volume":"8","author":"V Boyella","year":"2009","unstructured":"Boyella V, Onyebueke I, Farraj N, Graham-Hill S, El Younis C, Bergasa NV (2009) Prevalence of hepatitis C virus infection in patients with cardiomyopathy. Ann Hepatol 8:113\u2013115","journal-title":"Ann Hepatol"},{"key":"1086_CR3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1161\/01.RES.0000154263.70223.13","volume":"96","author":"T Omura","year":"2005","unstructured":"Omura T, Yoshiyama M, Hayashi T, Nishiguchi S, Kaito M, Horiike S et al (2005) Core protein of hepatitis C virus induces cardiomyopathy. Circ Res 96:148\u2013150","journal-title":"Circ Res"},{"key":"1086_CR4","first-page":"7629318","volume":"2016","author":"T Voulgaris","year":"2016","unstructured":"Voulgaris T, Sevastianos VA (2016) Atherosclerosis as extrahepatic manifestation of chronic infection with hepatitis C virus. Hepat Res Treat 2016:7629318","journal-title":"Hepat Res Treat"},{"key":"1086_CR5","doi-asserted-by":"crossref","first-page":"145155","DOI":"10.1053\/j.gastro.2015.09.007","volume":"150","author":"S Petta","year":"2016","unstructured":"Petta S, Maida M, Macaluso FS, Barbara M, Licata A, Craxi A et al (2016) Hepatitis C virus infection is associated with increased cardiovascular mortality: a meta-analysis of observational studies. Gastroenterology. 150:145\u2013155 (e4; quiz e15\u20136)","journal-title":"Gastroenterology"},{"key":"1086_CR6","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/jmv.24569","volume":"88","author":"BR Bang","year":"2016","unstructured":"Bang BR, Elmasry S, Saito T (2016) Organ system view of the hepatic innate immunity in HCV infection. J Med Virol 88:2025\u20132037","journal-title":"J Med Virol"},{"key":"1086_CR7","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.dld.2016.05.013","volume":"48","author":"F Gulli","year":"2016","unstructured":"Gulli F, Basile U, Gragnani L, Fognani E, Napodano C, Colacicco L et al (2016) Autoimmunity and lymphoproliferation markers in naive HCV-RNA positive patients without clinical evidences of autoimmune\/lymphoproliferative disorders. Dig Liver Dis 48:927\u2013933","journal-title":"Dig Liver Dis"},{"key":"1086_CR8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1586\/1744666X.2015.997214","volume":"11","author":"AL Zignego","year":"2015","unstructured":"Zignego AL, Gragnani L, Piluso A, Sebastiani M, Giuggioli D, Fallahi P et al (2015) Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection. Expert Rev Clin Immunol 11:15\u201331","journal-title":"Expert Rev Clin Immunol"},{"key":"1086_CR9","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.4254\/wjh.v7.i8.1074","volume":"7","author":"JL Narciso-Schiavon","year":"2015","unstructured":"Narciso-Schiavon JL, Schiavon Lde L (2015) Autoantibodies in chronic hepatitis C: a clinical perspective. World J Hepatol 7:1074\u20131085","journal-title":"World J Hepatol"},{"key":"1086_CR10","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jama.2014.7085","volume":"312","author":"A Kohli","year":"2014","unstructured":"Kohli A, Shaffer A, Sherman A, Kottilil S (2014) Treatment of hepatitis C: a systematic review. Jama 312:631\u2013640","journal-title":"Jama"},{"key":"1086_CR11","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s00392-015-0852-1","volume":"104","author":"T Hubner","year":"2015","unstructured":"Hubner T, Nickel T, Steinbeck G, Massberg S, Schramm R, Reichart B et al (2015) A single German center experience with intermittent inotropes for patients on the high-urgent heart transplant waiting list. Clin Res Cardiol 104:929\u2013934","journal-title":"Clin Res Cardiol"},{"key":"1086_CR12","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00392-016-1009-6","volume":"105","author":"S Ishihara","year":"2016","unstructured":"Ishihara S, Gayat E, Sato N, Arrigo M, Laribi S, Legrand M et al (2016) Similar hemodynamic decongestion with vasodilators and inotropes: systematic review, meta-analysis, and meta-regression of 35 studies on acute heart failure. Clin Res Cardiol 105:971\u2013980","journal-title":"Clin Res Cardiol"},{"key":"1086_CR13","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.amjcard.2016.04.023","volume":"118","author":"S Kumar","year":"2016","unstructured":"Kumar S, Deo SV, Altarabsheh SE, Dunlay SM, Sarabu N, Sareyyupoglu B et al (2016) Effect of hepatitis C positivity on survival in adult patients undergoing heart transplantation (from the United Network for Organ Sharing Database). Am J Cardiol 118:132\u2013137","journal-title":"Am J Cardiol"},{"key":"1086_CR14","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.3748\/wjg.v22.i4.1650","volume":"22","author":"S Belga","year":"2016","unstructured":"Belga S, Doucette KE (2016) Hepatitis C in non-hepatic solid organ transplant candidates and recipients: A new horizon. World J Gastroenterol 22:1650\u20131663","journal-title":"World J Gastroenterol"},{"key":"1086_CR15","first-page":"RA55","volume":"14","author":"MJ Sanchez","year":"2008","unstructured":"Sanchez MJ, Bergasa NV (2008) Hepatitis C associated cardiomyopathy: potential pathogenic mechanisms and clinical implications. Med Sci Monit 14:RA55\u2013R63","journal-title":"Med Sci Monit"},{"key":"1086_CR16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cardfail.2005.11.004","volume":"12","author":"A Matsumori","year":"2006","unstructured":"Matsumori A, Shimada T, Chapman NM, Tracy SM, Mason JW (2006) Myocarditis and heart failure associated with hepatitis C virus infection. J Card Fail 12:293\u2013298","journal-title":"J Card Fail"},{"key":"1086_CR17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/3-540-30822-9_7","volume":"55","author":"A Matsumori","year":"2006","unstructured":"Matsumori A (2006) Role of hepatitis C virus in cardiomyopathies. Ernst Schering Res Found Workshop 55:99\u2013120","journal-title":"Ernst Schering Res Found Workshop"},{"key":"1086_CR18","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00392-016-0986-9","volume":"105","author":"HP Schultheiss","year":"2016","unstructured":"Schultheiss HP, Piper C, Sowade O, Waagstein F, Kapp JF, Wegscheider K et al (2016) Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-beta treatment in patients with chronic viral cardiomyopathy. Clin Res Cardiol 105:763\u2013773","journal-title":"Clin Res Cardiol"},{"key":"1086_CR19","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1007\/s00392-016-0985-x","volume":"105","author":"T Weitsman","year":"2016","unstructured":"Weitsman T, Weisz G, Keren A, Hasin T (2016) Prompt benefit of early immunosuppressive therapy in acute lymphocytic myocarditis with persistent heart failure. Clin Res Cardiol 105:794\u2013796","journal-title":"Clin Res Cardiol"},{"key":"1086_CR20","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1161\/01.CIR.99.7.889","volume":"99","author":"M Pauschinger","year":"1999","unstructured":"Pauschinger M, Doerner A, Kuehl U, Schwimmbeck PL, Poller W, Kandolf R et al (1999) Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis. Circulation 99:889\u2013895","journal-title":"Circulation"},{"key":"1086_CR21","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1161\/01.CIR.99.10.1348","volume":"99","author":"M Pauschinger","year":"1999","unstructured":"Pauschinger M, Bowles NE, Fuentes-Garcia FJ, Pham V, Kuhl U, Schwimmbeck PL et al (1999) Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation 99:1348\u20131354","journal-title":"Circulation"},{"key":"1086_CR22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1161\/01.CIR.96.1.22","volume":"96","author":"M Okabe","year":"1997","unstructured":"Okabe M, Fukuda K, Arakawa K, Kikuchi M (1997) Chronic variant of myocarditis associated with hepatitis C virus infection. Circ 96:22\u201324","journal-title":"Circ"},{"key":"1086_CR23","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.jhep.2016.01.015","volume":"64","author":"A Padegimas","year":"1997","unstructured":"Padegimas A, Forde KA, Goldberg LR, Birati EY (2016) Myo-pericarditis secondary to ledipasvir-sofosbuvir therapy. J hepatol 64:1196\u20131198","journal-title":"J hepatol"},{"key":"1086_CR24","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1161\/CIRCULATIONAHA.108.788711","volume":"118","author":"Z Kaya","year":"2008","unstructured":"Kaya Z, Goser S, Buss SJ, Leuschner F, Ottl R, Li J, et al. (2008) Identification of cardiac troponin I sequence motifs leading to heart failure by induction of myocardial inflammation and fibrosis. Circ 118:2063\u20132072","journal-title":"Circ"},{"key":"1086_CR25","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.106.635664","volume":"114","author":"S Goser","year":"2006","unstructured":"Goser S, Andrassy M, Buss SJ, Leuschner F, Volz CH, Ottl R, et al. (2006) Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium. Circ 114:1693\u20131702","journal-title":"Circ"},{"key":"1086_CR26","first-page":"60","volume":"110","author":"A Haghikia","year":"2015","unstructured":"Haghikia A, Kaya Z, Schwab J, Westenfeld R, Ehlermann P, Bachelier K, et al. (2015) Evidence of autoantibodies against cardiac troponin I and sarcomeric myosin in peripartum cardiomyopathy. Basic Res Cardiol 110:60.","journal-title":"Circ"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-017-1086-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-017-1086-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-017-1086-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T22:49:48Z","timestamp":1568846988000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-017-1086-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,24]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["1086"],"URL":"https:\/\/doi.org\/10.1007\/s00392-017-1086-1","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,24]]}}}